Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives
MetadataShow full item record
Background: Numerous studies have shown a stronger relationship between ambulatory blood pressure (ABP), particularly night ABP, and cardiovascular events/mortality than for office blood pressure (OBP). A previous clinical trial (Syst-Eur) showed that pretreatment ABP was only a better predictor of outcome than OBP in placebo-treated participants. The current study in treated elderly hypertensives from the Second Australian National Blood Pressure study (ANBP2) examined whether pretreatment ABP was a better predictor of mortality than OBP over long-term (~11 years) follow-up. Participants and methods: ANBP2 was a comparative outcome trial in 6083 off-treatment or previously untreated elderly hypertensives. In the ABP substudy, at study entry, participants had ABP and nurse-performed OBP measurements. Cox proportional hazards analysis assessed the relationships between both OBP and ABP at study entry and 11-year all-cause and cardiovascular mortality, with results pooled from both active treatment phases. Results: In 702 participants, over a median of 10.8 years, including 6.7 years after the trial, 167 died (82 cardiovascular). Pretreatment 'night' systolic ABP and pulse pressure were the best predictors of '11-year' cardiovascular mortality (hazard ratios: 1.26; 95% confidence intervals: 1.10-1.45, P=0.001 and 1.18; 1.06-1.31, P=0.003, respectively) and all-cause mortality (hazard ratios: 1.15; 95% confidence intervals:1.05-1.28, P=0.005 and 1.09; 1.10-1.31, P=0.03, respectively). OBP was not a significant predictor of mortality. Conclusion: In actively treated elderly hypertensives participating in ANBP2, all-cause or cardiovascular deaths were significantly related to pretreatment ABP, particularly to night-time systolic ABP and pulse pressure, but not to OBP.
Showing items related by title, author, creator and subject.
Visit-to-visit (long-term) and ambulatory (short-term) blood pressure variability to predict mortality in an elderly hypertensive populationChowdhury, Enayet; Wing, L.; Jennings, G.; Beilin, L.; Reid, Christopher (2018)© Copyright 2018 Wolters Kluwer Health, Inc. All rights reserved. Objectives: To explore the association of different types of blood pressure (BP) variability measures estimated from either short-term ambulatory ...
Chowdhury, E.; Berk, M.; Nelson, M.; Wing, L.; Reid, Christopher (2018)Background:Both elevated blood pressure and/or depression increase the risk of cardiovascular disease and mortality. This study in treated elderly hypertensive patients explored the incidence of depression, its association ...
Change in Blood Pressure Variability Among Treated Elderly Hypertensive Patients and Its Association With MortalityChowdhury, Enayet ; Nelson, M.R.; Wing, L.M.H.; Jennings, G.L.R.; Beilin, L.J.; Reid, Christopher ; Bruce, A.; Beckinsale, P.; Thompson, J.; McMurchie, M.; Fraser, G.; Gleave, D.; Cope, V.; DeLooze, F.; Moore, S.; Dibben, C.; Newbury, J.; McDermott, B.; Willson, K.; Bear, C.; Harrap, S.; Johnston, C.; Ryan, P.; Brown, M.; Ryan, P.; Fletcher, P.; Feneley, M.; Dewar, E.; Marley, J.; Marley, J.; Moss, J.; Webb, P.; Glasziou, P.; Boyle, F.; Primrose, J.; Piterman, L.; De Looze, F.; Dickinson, J.; Gambrill, J.; Joseph, P.; Donnan, G.; Morgan, T.; Whitworth, J.; MacMahon, S.; Silagy, C. (2019)Background: Information is scarce regarding effects of antihypertensive medication on blood pressure variability (BPV) and associated clinical outcomes. We examined whether antihypertensive treatment changes BPV over time ...